GSKs Ebola vaccine trial soon

Written by Reuters | Updated: Aug 12 2014, 08:14am hrs
A clinical trial of an experimental vaccine against the deadly Ebola virus is set to start shortly, according to British drugmaker GlaxoSmithKline, which is co-developing the product with US

scientists. The world's worst outbreak of Ebola has killed nearly 1,000 people in West Africa, increasing pressure on researchers to accelerate their work on new medical interventions.

A company spokeswoman said on Sunday that the trial should get underway later this year, while GSK's partner the US National Institute of Allergy and Infectious Diseases (NIAID) said in a statement on its website it would start as early as fall 2014.Even if is fast-tracked, the new vaccine could not be ready for widespread deployment before 2015.